Ming Li
Biochemistry, Genetics and Molecular Biology · Indiana University
Publications
63
Citations
1,065
Est. group size
—
Recurring co-author estimate
Active years
23
Publishing since 2004
Ming Li studies how chemical modifications to DNA and RNA (epigenetics) influence disease, especially cancer and congenital heart defects. The work examines how these modifications turn genes on or off, how they affect tumor growth and the immune system, and how gene-environment interactions contribute to birth defects. Methods span laboratory experiments, animal models, and computational analysis of genomic data.
Publication activity grew to a peak around 2020-2022 and has been somewhat lower but steady in the most recent years, averaging about four papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- ALCAM-CD6 axis suppression: a key determinant of immune-mediated metastasis recurrence in stage III non-small cell lung cancer
Journal for ImmunoTherapy of Cancer · 2025
- Precise Characterization of Cellular States and Spatial Variable Patterns within Spatial Transcriptomics
Research Square · 2025
- Small-molecule therapies targeting tumor-associated macrophages in glioma: mechanisms and potential
International Immunopharmacology · 2025
- WTAP increases BMP2 expression to promote osteoblast differentiation and inhibit osteoblast senescence via m6A methylation of Sp1
Molecular Genetics and Genomics · 2024
- Comprehensive analysis of paraspeckle-associated gene modules unveils prognostic signatures and immunological relevance in multi-cancers
Discover Oncology · 2024
- Genome-wide screening and functional validation of methylation barriers near promoters
Nucleic Acids Research · 2024
- Gene–Folic Acid Interactions and Risk of Conotruncal Heart Defects: Results from the National Birth Defects Prevention Study
Genes · 2023
- WFDC2 Contributes to Epithelial–Mesenchymal Transition (EMT) by Activating AKT Signaling Pathway and Regulating MMP-2 Expression [Retraction]
Cancer Management and Research · 2022
- Exploring Epigenomic Datasets by ChIPseeker
Current Protocols · 2022
- Differential newborn <scp>DNA</scp> methylation among individuals with complex congenital heart defects and childhood lymphoma
Birth Defects Research · 2022
- Retraction: <i>SAMMSON</i> drives the self-renewal of liver tumor initiating cells through EZH2-dependent Wnt/β-catenin activation
Oncotarget · 2022
- Zebrafish model for human gut microbiome-related studies: advantages and limitations
Medicine in Microecology · 2021
- Demethylase-independent function of JMJD2D as a novel antagonist of p53 to promote Liver Cancer initiation and progression
Theranostics · 2020
- Double dissociation of inhibitory effects between the hippocampal TET1 and TET3 in the acquisition of morphine self‐administration in rats
Addiction Biology · 2020
- Epigenome‐Wide Tobacco‐Related Methylation Signature Identification and Their Multilevel Regulatory Network Inference for Lung Adenocarcinoma
BioMed Research International · 2020
- Addiction Biology×2
- Scientific Reports×2
- Genetic Epidemiology×2
- Briefings in Bioinformatics×2
- Figshare×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile